In addition, in mice with KrasG12D-and EGFRL858R-induced lung cancer, we not only found an increase in hnRNPA2/B1 levels, but also an altered ratio of hnRNPA2/B1 variant expression. This evidence concerns the gene HNRNPA2B1 and lung carcinoma.